Restoring aging T cell function to make them effective at fighting cancer
In a new study, Mass General Brigham researchers explore the causes of immune aging, a barrier to successful cancer immunotherapy, and identify a gene that may serve as an age-related prognostic marker and potential target for future cancer therapies.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.